25 May 2013
Keywords: nabi, starts, epick, study, biopharmaceuticals, usa, commenced
Article | 16 May 2005
Nabi Biopharmaceuticals of the USA has commenced its PhosLo (calcium acetate) EPICK study in patients suffering from Stage 4 chronic kidney
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com